DaVita Inc
DVA
View Detailed Chart
113.985USD
-0.425-0.37%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
8.09BMarket Cap
11.49P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.37%
5 Days
-1.05%
1 Month
-5.09%
6 Months
-19.54%
Year to Date
-23.78%
1 Year
-26.13%
View Detailed Chart
TradingKey Stock Score of DaVita Inc
Currency: USD Updated: 2025-12-26Key Insights
DaVita Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 41/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 138.59.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
DaVita Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
10
analysts
Hold
Current Rating
138.587
Target Price
+18.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
DaVita Inc Highlights
StrengthsRisks
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 12.82B.
Undervalued
The company’s latest PE is 11.49, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 36.29M shares, increasing 0.04% quarter-over-quarter.
Held by Scotia Canadian Dividend Fund
Star Investor Scotia Canadian Dividend Fund holds 4.93K shares of this stock.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
DaVita Inc Info
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Ticker SymbolDVA
CompanyDaVita Inc
CEORodriguez (Javier J)
Websitehttps://www.davita.com/
FAQs
What is the current price of DaVita Inc (DVA)?
The current price of DaVita Inc (DVA) is 113.985.
What is the symbol of DaVita Inc?
The ticker symbol of DaVita Inc is DVA.
What is the 52-week high of DaVita Inc?
The 52-week high of DaVita Inc is 179.600.
What is the 52-week low of DaVita Inc?
The 52-week low of DaVita Inc is 113.120.
What is the market capitalization of DaVita Inc?
The market capitalization of DaVita Inc is 8.09B.
What is the net income of DaVita Inc?
The net income of DaVita Inc is 936.34M.
Is DaVita Inc (DVA) currently rated as Buy, Hold, or Sell?
According to analysts, DaVita Inc (DVA) has an overall rating of Hold, with a price target of 138.587.
What is the Earnings Per Share (EPS TTM) of DaVita Inc (DVA)?
The Earnings Per Share (EPS TTM) of DaVita Inc (DVA) is 9.921.
Related Instruments
+1.30%
+0.29%
+0.03%
+0.11%
-0.49%
-0.05%
-0.13%
-0.75%
+0.67%
+0.59%
+1.91%
+0.59%
+0.34%
+0.09%
+0.04%
+0.64%
+0.26%
+0.05%
+0.26%
+0.67%
